Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab

Published:2010-10-18 Issue:5 Volume:30 Page:561-574
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Dunn E F,Iida M,Myers R A,Campbell D A,Hintz K A,Armstrong E A,Li C,Wheeler D L

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2010430.pdf

Reference78 articles.

1. Abram CL, Courtneidge SA . (2000). Src family tyrosine kinases and growth factor signaling. Exp Cell Res 254: 1–13.

2. Aligayer H, Boyd DD, Heiss MM, Abdalla EK, Curley SA, Gallick GE . (2002). Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer 94: 344–351.

3. Allegra CJ, Jessup JM, Somerfield MR, Hamilton SR, Hammond EH, Hayes DF et al. (2009). American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 27: 2091–2096.

4. Bardelli A, Siena S . (2010). Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. J Clin Oncol 28: 1254–1261.

5. Belsches AP, Haskell MD, Parsons SJ . (1997). Role of c-Src tyrosine kinase in EGF-induced mitogenesis. Front Biosci 2: d501–d518.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inactivation of necroptosis-promoting protein MLKL creates a therapeutic vulnerability in colorectal cancer cells;2024-09-06

2. A pH-responsive cetuximab-conjugated DMAKO-20 nano-delivery system for overcoming K-ras mutations and drug resistance in colorectal carcinoma;Acta Biomaterialia;2024-03

3. Experimental prognostic model integrating N6-methyladenosine-related programmed cell death genes in colorectal cancer;iScience;2024-01

4. Platycodin D represses β-catenin to suppress metastasis of cetuximab-treated KRAS wild-type colorectal cancer cells;Clinical & Experimental Metastasis;2023-06-16

5. Targeted cancer therapy: The future of drug combinations;Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3